Gastrointestinal Motility in Patients With Neuroendocrine Tumors

CompletedOBSERVATIONAL
Enrollment

13

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Neuroendocrine Tumor
Interventions
DEVICE

Magnetic Tracking System (MTS) and radio-opaque markers

MTS: A small magnetic pill (6x15mm) is swallowed by the patient and the movement of this pill is registered by a sensor (coordinates x,y,z angles θ, φ) and depicted af graphs on a computer screen. For determination of GITT a capsule containing 10 radio-opaque markers is ingested every day for six days, on day seven an abdominal x-ray is performed.

Trial Locations (1)

8000

Analfysiologisk afsnit, Aarhus University Hospital, Tage Hansensgade, entrance 11A, Aarhus

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novartis

INDUSTRY

collaborator

The Danish Medical Research Council

OTHER

lead

University of Aarhus

OTHER